During the past decade, CCOP, Central Illinois conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CCOP, Central Illinois" #1 sponsor was "SWOG Cancer Research Network" with 8 trials, followed by "Radiation Therapy Oncology Group" with 6 trials sponsored, "Eastern Cooperative Oncology Group" with 5 trials sponsored, "Gynecologic Oncology Group" with 5 trials sponsored and "NSABP Foundation Inc" with 5 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CCOP, Central Illinois" #1 collaborator was "National Cancer Institute (NCI)" with 27 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator, "Eastern Cooperative Oncology Group" with 2 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator and "Cancer and Leukemia Group B" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "CCOP, Central Illinois" are "Breast Cancer" (5 trials), "Ovarian Cancer" (4 trials), "Primary Peritoneal Cavity Cancer" (4 trials), "Lung Cancer" (3 trials) and "Gastric Cancer" (2 trials). Many other conditions were trialed in "CCOP, Central Illinois" in a lesser frequency.

Most popular intervention types in "CCOP, Central Illinois" are "Drug" (27 trials), "Radiation" (8 trials), "Procedure" (4 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "paclitaxel" (9 trials), "cyclophosphamide" (6 trials), "doxorubicin hydrochloride" (6 trials), "docetaxel" (4 trials) and "carboplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "CCOP, Central Illinois" are 17 trials for "All" genders, 11 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "CCOP, Central Illinois". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in CCOP, Central Illinois, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in CCOP, Central Illinois, 3 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".